CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
Author
Antonio Gualberto
Carden
+47 more
Cardillo
Chawla
Chugh
Clemmons
Cohen
David Olmos
de Bono
del Rincon
Demetri
Donghua Yin
Durai
Francis P Worden
Gibaldi
Gretchen N Batzel
Guler
Haluska
Haluska
Hankinson
Hartmann
Helman
Hidalgo
Ian Judson
Johann S de Bono
Karp
Kathryn Pritchard-Jones
L Rhoda Molife
Lacy
Laron
M Luisa Paccagnella
Manara
Massague
Michelle Scurr
Moses
Paul Haluska
Pennisi
Pollak
Ray-Coquard
Reiss
Rikhof
Rubin
Samani
Scotlandi
Scott H Okuno
Scott M Schuetze
Sophie Postel-Vinay
Tolcher
Van Glabbeke
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumors
Author
AK McCollum
AK McCollum
+38 more
AN Tse
BB Zhou
Bridget A. Stensgard
Charles Erlichman
CY Kramer
Cynthia Ten Eyck
David O. Toft
DB Solit
EA Ronnen
EI Heath
G Zachos
Gretchen Batzel
GS Nowakowski
HR Kim
JG Supko
Joleen Hubbard
JP Grenert
K Richter
KF Winklhofer
L Whitesell
L Whitesell
MP Goetz
MP Goetz
N Rhind
Paul Haluska
PG Richardson
R Bagatell
RK Ramanathan
RT Abraham
Rui Qin
S Modi
S. Percy Ivy
Sara Felten
SC Nair
SJ Arlander
TW Schulte
WB Pratt
Y Aoyagi
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
Author
A Camirand
A Gualberto
+47 more
AA Samani
AN West
Antonio Gualberto
BD Cohen
BL Wajchenberg
C Desbois-Mouthon
D Le Roith
D Sachdev
D Velazquez-Fernandez
D Yin
David Olmos
David Schteingart
DD Karp
Donghua Yin
FM Barlaskar
Frank Worden
G Di Cola
Gary D. Hammer
Gretchen N. Batzel
GW Allen
JC Bruning
JM Gee
JM Knowlden
Johann S. de Bono
KR Kalli
LR Wiseman
LS Kirschner
M Gibaldi
M Gronborg
M Terzolo
M. Luisa Paccagnella
MM Weber
MN Pollak
MQ Lacy
MR Cardillo
P Haluska
P Icard
Paul Haluska
PY Chang
R Durai
RT Kurmasheva
S Abe
SE Hankinson
TJ Giordano
X Wan
YS Chang
Z Laron
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref